Blog Book Chapters Case Studies Papers Patents Presentations Thought Leaders Webinars Whitepapers

May, 2022 , Chemistry Today

Chemistry Today: Panel Discussion on Catalysis

CatSci's Senior Scientist, Dr Alice Dunbabin, participated in the latest Chemistry Today panel discussion on Catalysis.

April, 2022 , Chemistry Today

Chemistry Today: Panel Discussion on Oligonucleotides

CatSci's Director of New Modalities, Dr Nigel Richardson, participated in the latest Chemistry Today panel discussion on Oligonucleotides.

2022

Application of the Polonovski Reaction: Scale-up of an Efficient and Environmentally Benign Opioid Demethylation

Org. Process Res. Dev. 2022

By: Antonio M. Ruda, Sofia Papadouli, Vargini Thangavadivale, and Jonathan D. Moseley et al.

April, 2022

Choosing the Right Technique to Increase Poor Drug Solubility in Solid Oral Dosage Formulations

Whilst good solubility is a target property in many drug discovery programs, a balance is often struck between solubility and potential efficacy which means that a poorly soluble molecule may need to be progressed.

By: Robert Dennehy

March, 2022 , Molecule to Market

The Opportunistic Entrepreneur

Our CEO, Dr Ross Burn discusses how pivoting in-line with the market's needs and having big aims of becoming an innovative medicines development partner led to business growth.

By: Ross Burn

March, 2022

Developing a crystallisation for a disaccharide​

CatSci's material science team was tasked with developing a crystallization for a disaccharide that was produced from an enzymatic reaction.

By: CatSci